Please use this identifier to cite or link to this item:
Title: Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adenocarcinoma/*drug therapy,Adult,Aged,Antineoplastic Agents/*administration & dosage/adverse effects/pharmacokinetics,Disease Progression,Disease-Free Survival,Female,Glucose/analogs & derivatives,Humans,Ifosfamide/analogs & derivatives,Infusions, Intravenous,Male,Middle Aged,Pancreatic Neoplasms/*drug therapy,Phosphoramide Mustards/*administration & dosage/adverse effects/pharmacokinetics,Prospective Studies,Treatment Outcome
ISSN: 0959-8049
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Briasoulis-2003-Glufosfamide adminis.pdf218.17 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons